Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 186

Similar articles for PubMed (Select 16855266)

1.

Outcome of heart failure with preserved ejection fraction in a population-based study.

Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP.

N Engl J Med. 2006 Jul 20;355(3):260-9.

2.

Trends in prevalence and outcome of heart failure with preserved ejection fraction.

Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM.

N Engl J Med. 2006 Jul 20;355(3):251-9.

3.

Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.

Philbin EF, Rocco TA Jr, Lindenmuth NW, Ulrich K, Jenkins PL.

Am J Med. 2000 Dec 1;109(8):605-13.

PMID:
11099679
4.

Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).

Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, Yokota T, Goto D, Yokoshiki H, Kato N, Takeshita A, Tsutsui H; JCARE-CARD Investigators.

Circ J. 2009 Oct;73(10):1893-900. Epub 2009 Jul 31. Erratum in: Circ J. 2009 Dec;73(12):2365.

5.

The independent effects of left ventricular ejection fraction on short-term outcomes and resource utilization following hospitalization for heart failure.

Harjai KJ, Nunez E, Turgut T, Shah MP, Humphrey JS, Newman J, Cheirif J, Smart FW, Ventura HO.

Clin Cardiol. 1999 Mar;22(3):184-90.

PMID:
10084060
6.

Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline.

Smith GL, Masoudi FA, Vaccarino V, Radford MJ, Krumholz HM.

J Am Coll Cardiol. 2003 May 7;41(9):1510-8.

7.

Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study.

Tribouilloy C, Rusinaru D, Mahjoub H, Soulière V, Lévy F, Peltier M, Slama M, Massy Z.

Eur Heart J. 2008 Feb;29(3):339-47. Epub 2007 Dec 22.

8.

Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.

Pérez de Isla L, Zamorano J, Hernández N, Contreras L, Rodrigo JL, Almería C, Aubele AL, Mataix L, Macaya C.

J Cardiovasc Med (Hagerstown). 2008 Oct;9(10):1011-5. doi: 10.2459/JCM.0b013e3282fbca87.

PMID:
18799963
9.
11.

Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.

Ezekowitz JA, Lee DS, Tu JV, Newman AM, McAlister FA.

Am J Cardiol. 2008 Jul 1;102(1):79-83. doi: 10.1016/j.amjcard.2008.02.102. Epub 2008 May 9.

PMID:
18572040
12.

Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial.

Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB, Lopez-Sendon J, Teerlink JR, White M, McMurray JJ, Komajda M, McKelvie R, Ptaszynska A, Hetzel SJ, Massie BM, Carson PE; I-Preserve Investigators.

Circulation. 2010 Mar 30;121(12):1393-405. doi: 10.1161/CIRCULATIONAHA.109.909614. Epub 2010 Mar 15.

13.

Clinical presentation, hospital length of stay, and readmission rate in patients with heart failure with preserved and decreased left ventricular systolic function.

Malki Q, Sharma ND, Afzal A, Ananthsubramaniam K, Abbas A, Jacobson G, Jafri S.

Clin Cardiol. 2002 Apr;25(4):149-52.

PMID:
12000071
14.

Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure.

Di Salvo TG, Mathier M, Semigran MJ, Dec GW.

J Am Coll Cardiol. 1995 Apr;25(5):1143-53.

15.

Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction.

Alla F, Al-Hindi AY, Lee CR, Schwartz TA, Patterson JH, Adams KF Jr.

Am Heart J. 2007 Jun;153(6):1074-80.

PMID:
17540212
16.

[Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].

Macín SM, Perna ER, Címbaro Canella JP, Alvarenga P, Pantich R, Ríos N, Farías EF, Badaracco JR.

Rev Esp Cardiol. 2004 Jan;57(1):45-52. Spanish.

17.

Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.

Gavazzi A, Berzuini C, Campana C, Inserra C, Ponzetta M, Sebastiani R, Ghio S, Recusani F.

J Heart Lung Transplant. 1997 Jul;16(7):774-85.

PMID:
9257260
18.

Irbesartan in patients with heart failure and preserved ejection fraction.

Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A; I-PRESERVE Investigators.

N Engl J Med. 2008 Dec 4;359(23):2456-67. doi: 10.1056/NEJMoa0805450. Epub 2008 Nov 11.

19.

Statin therapy and mortality among patients hospitalized with heart failure and preserved left ventricular function--a preliminary report.

Roik M, Starczewska MH, Huczek Z, Kochanowski J, Opolski G.

Acta Cardiol. 2008 Dec;63(6):683-92.

PMID:
19157162
20.

Improving outcomes in heart failure in the community: long-term survival benefit of a disease-management program.

Akosah KO, Schaper AM, Haus LM, Mathiason MA, Barnhart SI, McHugh VL.

Chest. 2005 Jun;127(6):2042-8.

PMID:
15947318
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk